Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2216372생성일: 2026년 10월 26일
Triethylamine → 3-[2-Benzyl-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]-3-pyridyl]ethynyl-3-piperidinol
https://huagongshe.com/reaction/2216372
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | 2-Benzyl-3-iodo-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridine | HCID 11384307 | — |
| 반응물 | Ammonia chloride | HCID 20976574 | — |
| 반응물 | 1-Boc-3-ethynyl-3-hydroxypiperidine | HCID 21942248 | — |
| 촉매 | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| 촉매 | HCID 178418397 | HCID 178418397 | — |
| 용매 | Methanol | HCID 887 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | 3-[2-Benzyl-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]-3-pyridyl]ethynyl-3-piperidinol | HCID 9801513 | 86.6% |
반응 단계
A mixture of 450 mg of 2-benzyl-3-iodo-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1yl]-pyridine (Production Example 1), 272 mg of 1-tert-butoxycarbonyl-3-ethynyl-3-piperidinol (Production Example 15), 63.6 mg of tetrakis(triphenylphosphine)palladium (0), 41.9 mg of copper (I) iodide, 460 μl of triethylamine, 5 ml of methanol and 1 ml of N,N-dimethyl formamide was heated under reflux under nitrogen atmosphere for 3 hours. After standing to cool, water, ethyl acetate, an aqueous ammonia chloride solution were added to the reaction mixture, and the organic layer was washed with water and brine, dried over anhydrous magnesium sulfate and then the solvent was removed. To the residue were added 2 ml of trifluoroacetic acid and 2 ml of dichloromethane, followed by stirring at room temperature for 1 hour. The reaction mixture was neutralized with an aqueous sodium hydrogen carbonate solution and an organic layer was separated by adding ethyl acetate. The organic layer was washed with brine, dried over anhydrous magnesium sulfate and the solvent was removed. The residue was purified by NH-silica gel column chromatography with 5% methanol/ethyl acetate, to give 387 mg of the entitled compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07112593B2 |
|---|
| 출처 데이터셋 | uspto-grants-2006_09 |
|---|
| ORD ID | ord-80ac6040bb384acbabcb253af20def6e |
|---|
| 출처 메모 | uspto-grants-2006_09 |
|---|